Supplemental Materials: Orismilast in moderate-to-severe psoriasis: Efficacy and safety from a 16-week, randomized, double-blinded, placebo-controlled, dose-finding, phase 2b trial (IASOS)_JAAD

Name: Supplemental Materials: Orismilast in moderate-to-severe psoriasis: Efficacy and safety from a 16-week, randomized, double-blinded, placebo-controlled, dose-finding, phase 2b trial (IASOS)_JAAD
Creator: Mendeley Data
Published: 2025-04-01 05:11:42
License: 暂无描述

DataCite Commons2025-04-01 更新2025-04-16 收录

下载链接：

https://data.mendeley.com/datasets/dkbxwxmtfv

下载链接

链接失效反馈

官方服务：

资源简介：

Supplemental information for the manuscript in the Journal of the American Academy of Dermatology (JAAD): "Orismilast in moderate-to-severe psoriasis: Efficacy and safety from a 16-week, randomized, double-blinded, placebo-controlled, dose-finding, phase 2b trial (IASOS)"

提供机构：

Mendeley Data

创建时间：

2023-11-08